Protective Effects of Carvedilol in the Myocardium
Authors:
- Antoine BrilABAntoine Bril
- Robert R RuffoloRRRobert R Ruffolo
- 1 December 1997
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 80 (11) , 41L-45L
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- A hydroxylated analog of the β-adrenoceptor antagonist, carvedilol, affords exceptional antioxidant protection to postischemic rat heartsFree Radical Biology and Medicine, 1996
- Carvedilol improves function and reduces infarct size in the feline myocardium by protecting against lethal reperfusion injuryEuropean Journal of Pharmacology, 1996
- Carvedilol Protects Against Lethal Reperfusion Injury Through Antiadrenergic MechanismsJournal of Cardiovascular Pharmacology, 1996
- Carvedilol, a novel vasodilating beta-blocker with the potential for cardiovascular organ protectionEuropean Heart Journal, 1996
- Carvedilol prevents low-density lipoprotein (LDL)-enhanced monocyte adhesion to endothelial cells by inhibition of LDL oxidationEuropean Journal of Pharmacology, 1995
- Reperfusion injury induces apoptosis in rabbit cardiomyocytes.Journal of Clinical Investigation, 1994
- Carvedilol, a new vasodilating adrenoceptor blocker antihypertensive drug, protects endothelial cells from damage initiated by xanthine-xanthine oxidase and neutrophilsCardiovascular Research, 1994
- Myocardial Protection with CarvedilolJournal of Cardiovascular Pharmacology, 1992
- Carvedilol (Kredex®) Reduces Infarct Size in a Canine Model of Acute Myocardial InfarctionPharmacology, 1991
- Effects of the free radical generating system FeCl3/ADP on reperfusion arrhythmias of rat hearts and electrical activity of canine Purkinje fibresCardiovascular Research, 1990